FDA denies approval for Alimera's eye implant; shares fall

(Reuters) - Alimera Sciences Inc said U.S. health regulators declined to approve its eye implant for retinal swelling and indicated the need for a new clinical trial, sending the company's shares down 26 percent before the bell. The company said the U.S. Food and Drug Administration identified "concerns regarding the benefit to risk and safety profiles" of Iluvien in its complete response letter. Alimera licensed the drug from pSivida Corp in 2005. PSivida's shares fell 56 percent in trading before the bell on Friday. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/fda-denies-approval-alimeras-eye-implant-shares-fall-112712681--finance.html